WallStreetZenWallStreetZen

NYSE: HUM
Humana Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HUM

Based on 14 analysts offering 12 month price targets for Humana Inc

Min Forecast
$245.00-11.93%
Avg Forecast
$298.79+7.4%
Max Forecast
$347.00+24.73%

Should I buy or sell HUM stock?

Based on 14 analysts offering ratings for Humana Inc.

Buy
Strong Buy
1 analysts 7.14%
Buy
4 analysts 28.57%
Hold
9 analysts 64.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HUM's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates HUM as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their HUM stock forecasts and price targets.

HUM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-10
lockedlocked$00.00+00.00%2025-10-09
lockedlocked$00.00+00.00%2025-10-07
lockedlocked$00.00+00.00%2025-10-03
lockedlocked$00.00+00.00%2025-09-22
Bernstein
Bottom 12%
12
BuyMaintains$341.00+22.58%2025-09-05
RBC Capital
Top 17%
84
BuyMaintains$322.00+15.75%2025-08-21
Argus Research
Top 21%
80
HoldReiterates$281.99+1.37%2025-08-14
Morgan Stanley
Top 6%
95
HoldMaintains$277.00-0.43%2025-07-31
Piper Sandler
Bottom 13%
13
HoldMaintains$272.00-2.23%2025-07-31

1 of 2

Forecast return on equity

Is HUM forecast to generate an efficient return?

Company
22.56%
Industry
24.07%
Market
143.01%
HUM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HUM forecast to generate an efficient return on assets?

Company
8.17%
Industry
7.22%
HUM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HUM earnings per share forecast

What is HUM's earnings per share in the next 3 years based on estimates from 31 analysts?

Avg 1 year Forecast
$17.24+31.88%
Avg 2 year Forecast
$13.60+4.05%
Avg 3 year Forecast
$20.79+59.09%
HUM's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

HUM revenue forecast

What is HUM's revenue in the next 3 years based on estimates from 28 analysts?

Avg 1 year Forecast
$129.4B+5.08%
Avg 2 year Forecast
$136.5B+10.84%
Avg 3 year Forecast
$145.8B+18.42%
HUM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HUM earnings growth forecast

How is HUM forecast to perform vs Healthcare Plans companies and vs the US market?

Company
12.1%
Industry
33.42%
Market
41%
HUM's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HUM's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HUM's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HUM revenue growth forecast

How is HUM forecast to perform vs Healthcare Plans companies and vs the US market?

Company
5.69%
Industry
4.25%
Market
24.88%
HUM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HUM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HUM vs Healthcare Plan Stocks

TickerPricePrice TargetUp/downsideConsensus
HUM$278.19$298.79+7.40%Buy
CNC$35.37$37.33+5.55%Hold
MOH$153.06$199.00+30.01%Hold
OSCR$18.00$13.33-25.93%Sell
ALHC$16.86$18.25+8.24%Buy
View Top Healthcare Plan Stocks

Humana Stock Forecast FAQ

Is Humana Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NYSE: HUM) stock is to Buy HUM stock.

Out of 14 analysts, 1 (7.14%) are recommending HUM as a Strong Buy, 4 (28.57%) are recommending HUM as a Buy, 9 (64.29%) are recommending HUM as a Hold, 0 (0%) are recommending HUM as a Sell, and 0 (0%) are recommending HUM as a Strong Sell.

If you're new to stock investing, here's how to buy Humana stock.

What is HUM's earnings growth forecast for 2025-2027?

(NYSE: HUM) Humana's forecast annual earnings growth rate of 12.1% is not forecast to beat the US Healthcare Plans industry's average forecast earnings growth rate of 33.42%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41%.

Humana's earnings in 2025 is $1,576,000,000.On average, 31 Wall Street analysts forecast HUM's earnings for 2025 to be $2,073,149,398, with the lowest HUM earnings forecast at $2,003,728,505, and the highest HUM earnings forecast at $2,184,737,592. On average, 31 Wall Street analysts forecast HUM's earnings for 2026 to be $1,635,636,602, with the lowest HUM earnings forecast at $1,228,167,707, and the highest HUM earnings forecast at $2,001,623,748.

In 2027, HUM is forecast to generate $2,500,835,987 in earnings, with the lowest earnings forecast at $1,791,569,016 and the highest earnings forecast at $3,136,929,583.

What is HUM's revenue growth forecast for 2025-2027?

(NYSE: HUM) Humana's forecast annual revenue growth rate of 5.69% is forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 4.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.88%.

Humana's revenue in 2025 is $123,110,000,000.On average, 28 Wall Street analysts forecast HUM's revenue for 2025 to be $15,559,084,136,754, with the lowest HUM revenue forecast at $14,504,781,371,400, and the highest HUM revenue forecast at $16,294,426,038,120. On average, 27 Wall Street analysts forecast HUM's revenue for 2026 to be $16,412,172,148,921, with the lowest HUM revenue forecast at $14,332,792,670,230, and the highest HUM revenue forecast at $18,433,941,426,311.

In 2027, HUM is forecast to generate $17,534,548,763,829 in revenue, with the lowest revenue forecast at $14,905,286,528,670 and the highest revenue forecast at $19,826,809,362,150.

What is HUM's forecast return on assets (ROA) for 2025-2028?

(NYSE: HUM) forecast ROA is 8.17%, which is higher than the forecast US Healthcare Plans industry average of 7.22%.

What is HUM's Price Target?

According to 14 Wall Street analysts that have issued a 1 year HUM price target, the average HUM price target is $298.79, with the highest HUM stock price forecast at $347.00 and the lowest HUM stock price forecast at $245.00.

On average, Wall Street analysts predict that Humana's share price could reach $298.79 by Oct 10, 2026. The average Humana stock price prediction forecasts a potential upside of 7.4% from the current HUM share price of $278.19.

What is HUM's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: HUM) Humana's current Earnings Per Share (EPS) is $13.07. On average, analysts forecast that HUM's EPS will be $17.24 for 2025, with the lowest EPS forecast at $16.66, and the highest EPS forecast at $18.17. On average, analysts forecast that HUM's EPS will be $13.60 for 2026, with the lowest EPS forecast at $10.21, and the highest EPS forecast at $16.64. In 2027, HUM's EPS is forecast to hit $20.79 (min: $14.90, max: $26.08).

What is HUM's forecast return on equity (ROE) for 2025-2028?

(NYSE: HUM) forecast ROE is 22.56%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.